NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Design Considerations for Evaluating the Impact of PEPFAR is the summary of a 2-day workshop on methodological, policy, and practical design considerations for a future evaluation of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) interventions carried out under the President’s Emergency Plan for AIDS Relief (PEPFAR), which was convened by the Institute of Medicine (IOM) on April 30 and May 1, 2007. Participants at the workshop included staff of the U.S. Congress; PEPFAR officials and implementers; major multilateral organizations such as The Global Fund to Fight AIDS, Malaria, and Tuberculosis (The Global Fund), the Joint United Nations Programme on HIV/AIDS (UNAIDS), and the World Bank; representatives from international nongovernmental organizations; experienced evaluation experts; and representatives of partner countries, particularly the PEPFAR focus countries. The workshop represented a final element of the work of the congressionally mandated IOM Committee for the Evaluation of PEPFAR Implementation, which published a report of its findings in 2007 evaluating the first 2 years of implementation, but could not address longer term impact evaluation questions.
Contents
- THE NATIONAL ACADEMIES
- Reviewers
- Preface
- Overview
- 1. Introduction to Impact Evaluation for PEPFAR
- 2. Envisioning a Meaningful Impact Evaluation for PEPFAR: Moving Beyond Counting
- 3. Designing an Evaluation That Incorporates the Guiding Principles of Coordination, Harmonization, and Capacity Building
- 4. Designing an Impact Evaluation with Robust Methodologies
- Appendix A Agenda
- Appendix B Abbreviations and Acronyms
- Appendix C List of Participants
- Appendix D References
Rapporteurs: Clara Cohen, Michele Orza and Deepali Patel.
This study was supported by Contract No. SAQMPD05D1147 (STAT-7394) between the National Academy of Sciences and the Department of State. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project.
Suggested citation:
IOM (Institute of Medicine). 2008. Design considerations for evaluating the impact of PEPFAR: Workshop summary. Washington, DC: The National Academies Press.
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.
- NLM CatalogRelated NLM Catalog Entries
- United States global health policy: HIV/AIDS, maternal and child health, and The President's Emergency Plan for AIDS Relief (PEPFAR).[AIDS. 2010]United States global health policy: HIV/AIDS, maternal and child health, and The President's Emergency Plan for AIDS Relief (PEPFAR).Leeper SC, Reddi A. AIDS. 2010 Sep 10; 24(14):2145-9.
- Lessons learned from a decade of partnership between PEPFAR and the Global Fund: a case study from Tanzania.[Health Aff (Millwood). 2012]Lessons learned from a decade of partnership between PEPFAR and the Global Fund: a case study from Tanzania.Bilimoria NF. Health Aff (Millwood). 2012 Jul; 31(7):1415-21.
- Monitoring HIV and AIDS Related Policy Reforms: A Road Map to Strengthen Policy Monitoring and Implementation in PEPFAR Partner Countries.[PLoS One. 2016]Monitoring HIV and AIDS Related Policy Reforms: A Road Map to Strengthen Policy Monitoring and Implementation in PEPFAR Partner Countries.Lane J, Verani A, Hijazi M, Hurley E, Hagopian A, Judice N, MacInnis R, Sanford S, Zelek S, Katz A. PLoS One. 2016; 11(2):e0146720. Epub 2016 Feb 25.
- Review The United States President's Emergency Plan for AIDS Relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic.[J Acquir Immune Defic Syndr. 2...]Review The United States President's Emergency Plan for AIDS Relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic.Goosby E, Dybul M, Fauci AS, Fu J, Walsh T, Needle R, Bouey P. J Acquir Immune Defic Syndr. 2012 Aug 15; 60 Suppl 3:S51-6.
- Review Evaluation of PEPFAR[ 2013]Review Evaluation of PEPFARCommittee on the Outcome and Impact Evaluation of Global HIV/AIDS Programs Implemented Under the Lantos-Hyde Act of 2008, Board on Global Health, Board on Children, Youth, and Families, Institute of Medicine. 2013 Jun 27
- Design Considerations for Evaluating the Impact of PEPFARDesign Considerations for Evaluating the Impact of PEPFAR
Your browsing activity is empty.
Activity recording is turned off.
See more...